PF-08049820

· Pfizer

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PF-08049820, covering 2025-11-17 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema [Phase 2]